About: Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $10.47 (+1.45%)
NVAX NASDAQ Novavax Inc
Novavax Inc share price
Atividade de preço de NVAX
Último preço
$ 10,470
Variação (24h)
0,15 USD (1,45%)
Volume
2.79M
Volume (média 4 sem.)
-
Abertura
$ 10,19
Variação do dia
$ 10,19 - $ 10,62
Fechamento anterior
$ 10,32
Último negócio
29 Oct, 8:28 pm GMT+0
Atrasado
29 Oct, 8:28 pm GMT+0
NVAX price performance
Atrasado
29 Oct, 8:28 pm GMT+0
quote.marketSignals